- Home
- RBA vs INSM Comparison
RBA vs INSM Comparison
Compare RBA & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBA
- INSM
- Stock Information
- Founded
- RBA 1958
- INSM 1988
- Country
- RBA United States
- INSM United States
- Employees
- RBA N/A
- INSM N/A
- Industry
- RBA Business Services
- INSM Biotechnology: Pharmaceutical Preparations
- Sector
- RBA Consumer Discretionary
- INSM Health Care
- Exchange
- RBA Nasdaq
- INSM Nasdaq
- Market Cap
- RBA 19.8B
- INSM 17.3B
- IPO Year
- RBA 1998
- INSM 2000
- Fundamental
- Price
- RBA $105.61
- INSM $96.71
- Analyst Decision
- RBA Buy
- INSM Strong Buy
- Analyst Count
- RBA 6
- INSM 17
- Target Price
- RBA $111.42
- INSM $106.80
- AVG Volume (30 Days)
- RBA 962.4K
- INSM 6.2M
- Earning Date
- RBA 08-05-2025
- INSM 08-07-2025
- Dividend Yield
- RBA 1.10%
- INSM N/A
- EPS Growth
- RBA 22.04
- INSM N/A
- EPS
- RBA 2.03
- INSM N/A
- Revenue
- RBA $4,328,100,000.00
- INSM $381,030,000.00
- Revenue This Year
- RBA $4.62
- INSM $28.03
- Revenue Next Year
- RBA $4.06
- INSM $120.54
- P/E Ratio
- RBA $52.02
- INSM N/A
- Revenue Growth
- RBA 2.27
- INSM 20.77
- 52 Week Low
- RBA $70.38
- INSM $60.40
- 52 Week High
- RBA $109.25
- INSM $106.83
- Technical
- Relative Strength Index (RSI)
- RBA 51.77
- INSM 59.60
- Support Level
- RBA $104.51
- INSM $98.85
- Resistance Level
- RBA $106.63
- INSM $106.83
- Average True Range (ATR)
- RBA 1.69
- INSM 3.05
- MACD
- RBA -0.10
- INSM -1.18
- Stochastic Oscillator
- RBA 58.62
- INSM 9.36
About RBA RB Global Inc.
RB Global operates the world's largest auction for heavy equipment. The company started as a live auctioneer of industrial equipment; since then it has greatly expanded its operations to include the sale of construction, agricultural, oilfield, and transportation equipment. RB Global operates over 40 live auction sites in more than 12 countries, along with online marketplaces, including IronPlanet, Marketplace-E, and GovPlanet. Its agricultural auctions are frequently much smaller venues and can include liquidations of single farms. The company holds over 300 auctions yearly and sells $6 billion worth of equipment.
About INSM Insmed Incorporated
Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.